Ignite Creation Date:
2025-12-24 @ 11:21 PM
Ignite Modification Date:
2026-05-25 @ 5:05 AM
Study NCT ID:
NCT00803556
Status:
COMPLETED
Last Update Posted:
2011-06-27
First Post:
2008-12-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Trial of the Combination of Intravenous Alvespimycin (KOS-1022), Trastuzumab With or Without Paclitaxel in Patients With Advanced Solid Tumor Malignancies or Her2 Positive Metastatic Breast Cancer Who Have Previously Failed Trastuzumab Therapy
Sponsor:
Bristol-Myers Squibb
Organization: